SCHEMBL8485124

SCHEMBL8485124

CCCCc1cccc2c1C(C(=O)N(CCC)N1CCC(N3Cc4ccccc4C3)CC1)c1ccccc1-2

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ OPRK1 P41145 1/20 0.33
▸ HTR1A P08908 1/20 0.32
▸ DRD2 P14416 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8668077 0.95 OPRK1 (0.32) OPRK1HTR1ADRD2
SCHEMBL8503795 0.91 OPRK1 (0.31) OPRK1
SCHEMBL8485150 0.88 L3MBTL1 (0.41) OPRK1DRD2
SCHEMBL8485599 0.84 MTR (0.38) —
SCHEMBL8479247 0.80 SCN1A (0.37) —
SCHEMBL8480413 0.80 TMEM97 (0.35) OPRK1
SCHEMBL8669690 0.79 UTS2R (0.39) DRD2
SCHEMBL8487928 0.79 SCN1A (0.36) —
SCHEMBL8485120 0.78 TSHR (0.36) OPRK1HTR1ADRD2
SCHEMBL8479611 0.78 SCN1A (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5739135-A PREVENTING OR TREATING ATHEROSCLEROSIS, PANCREATITIS SECONDARY TO HYPERTRIGLYCERIDEMIA, HYPERGLYCEMIA, OBESITY BRISTOL-MYERS SQUIBB COMPANY (US) 1998-04-14 — — US claimed
US-5883099-A TREATMENT OF ATHERSCLEROSIS, PANCREATITIS OBESITY OR HYPERGLYCEMIA BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-16 — — US disclosed
US-5739135-A PREVENTING OR TREATING ATHEROSCLEROSIS, PANCREATITIS SECONDARY TO HYPERTRIGLYCERIDEMIA, HYPERGLYCEMIA, OBESITY BRISTOL-MYERS SQUIBB COMPANY (US) 1998-04-14 — — US disclosed
Send feedback